Even though a human skill-set is hugely expansive by default, it doesn’t stop us from pursuing something bigger. This is largely why we have been able to grow in such a notable manner, and consequentially, achieve some unbelievable milestones over the years. Now, these milestones are surely loaded to the brim, but none of them can be deemed as impressive as technology. We say so, because technology has guided us towards an altitude that wasn’t even in our sight before. You see, fitting well with the human tendency to grow on a rather consistent basis, the creation will soon manage to get big enough to take over the entire spectrum, including a highly-critical area like the medical sector. While blending technology into the healthcare mix wasn’t always a part of the plan, the move will pay off big time, as it practically transformed the way we used to look at the said discipline. The obsolete ideas were no longer running the show. Instead, for once, the world had a healthcare model that was more mindful about the patient’s needs than anything else. Luckily, this dynamic still enjoys all the momentum, and the same was evident in Paige’s latest announcement.
Paige, an AI-based diagnostic software provider, has officially launched a new product called Paige Breast Lymph Node, which is an AI software designed to help pathologists in terms of detecting breast cancer that has spread to the lymph nodes. Assessing lymph nodes in a meticulous manner is not quite the easiest thing in the world, especially when you also have to spot tiny collections of cancer cells called micrometastases, so a cutting-edge tool like Paige’s latest product should trigger a major breakthrough. According to certain reports, the software will work in conjunction with the company’s proprietary technology, TissueMap. Once the stated assessment is completed, TissueMap is going to highlight all areas that might be affected by the cancer or are at a risk of it. The Paige Breast Lymph Node software follows up on the AI momentum created by Paige Prostrate, which was another one of its advanced takes on healthcare.
“We know that it is a struggle for pathologists to find small metastases, which is a burdensome and time-consuming task,” said Dr. Juan Retamero, medical director at Paige. “Paige Breast Lymph Node has been designed to detect small tumor deposits, helping pathologists be more efficient and safe in this regard.”
At present, the technology is only available for research purposes, but the company is in the process of getting regulatory approval across various international markets.
